The vector of anti-CEACAM5 T cell receptor (TCR) is constructed for the engineering of T cell to target Human CEACAM5. The T cells are genetically modified through transduction with a retroviral vector expressing CEACAM5-specific T cell receptor. And the vector product was designed for the treatment of Colorectal cancer.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
|CAR-CQ3889||Anti-CEACAM5 (CEA31) h(CD28-CD3ζ) CAR, pCDCAR1|
|CAR-CQ0475||Anti-CEACAM5 (CCAM5-1) h(41BB-CD3ζ) CAR, pCDCAR1|
|CAR-WFY6107||Anti-CEACAM5 (CBFYC-1682) h(CD28-CD3ζ) CAR, pCDCAR1|
|CAR-CQ3885||Anti-CEACAM5 (C66/1292) h(CD28-CD3ζ) CAR, pCDCAR1|
|CAR-CQ3882||Anti-CEACAM5 (C66/1030) h(CD28-CD3ζ) CAR, pCDCAR1|
|CAR-T-2-M314-4Z||Anti-CEA scFv h(CD4-CD3ζ) CART, pCDCAR1|
|VP-CAR-LC807||Lenti-CEA CAR (scFv-CD28-41BB-CD3ζ, MFE23) Viral Particle|
|DMAb-2858-FY||Rabbit Anti-CEACAM5 DNA-encoded mAb (CBFYC-1686), pVAX1|
|DMAb-2847-FY||Rabbit Anti-CEACAM5 DNA-encoded mAb (CBFYC-0054), pVAX1|
|DMAb-2857-FY||Mouse Anti-CEACAM5 DNA-encoded mAb (CBFYC-1685), pVAX1|
Copyright © 2007 - 2019 Creative Biolabs. All Rights Reserved